Altre lingue Biomerica, Inc.

Azioni

BMRA

US09061H3075

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:01 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,56 ^USD	-6,67%		-15,81%	-55,20%

29/04	Biomerica conclude un accordo di distribuzione per fornire test di screening a domicilio negli Emirati Arabi Uniti	MT
29/04	Biomerica e l'Azienda Sanitaria degli Emirati Arabi Uniti forgiano un percorso per migliorare lo screening del colon-retto e del seno, con un accordo di distribuzione pluriennale esclusivo.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Biomerica : Investor Presentation	04/05
Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	29/04
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	29/04
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	29/04
Biomerica Reports Third Quarter 2024 Financial Results	15/04
Biomerica provides update on inFoods® IBS expansion	15/04
Biomerica Provides Update on inFoods IBS Expansion	15/04
Biomerica Reports Third Quarter 2024 Financial Results	13/04
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	12/04
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference	28/03
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board	21/02
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	21/02
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica	23/01
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	23/01
Biomerica Reports Second Quarter 2024 Financial Results	16/01
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	16/01
Top Premarket Decliners	19/12
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test	18/12
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population	18/12
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	18/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Biomerica, Inc.

Azioni

BMRA

US09061H3075

Altre lingue

Filtri